Mirum Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2018 | $2.4M | $52.0M | $52.0M |
| Jun 2019 | $12.4M | $104.3M | $41.8M |
| Sep 2019 | $12.1M | $158.3M | $30.8M |
| Dec 2019 | $16.4M | $146.7M | $12.0M |
| Mar 2020 | $16.7M | $172.8M | $72.0M |
| Jun 2020 | $19.6M | $155.8M | $83.0M |
| Sep 2020 | $21.6M | $141.9M | $48.8M |
| Dec 2020 | $68.8M | $240.9M | $142.1M |
| Mar 2021 | $88.4M | $222.2M | $90.7M |
| Jun 2021 | $151.9M | $247.7M | $91.9M |
| Sep 2021 | $178.8M | $235.2M | $55.8M |
| Dec 2021 | $174.4M | $294.7M | $31.3M |
| Mar 2022 | $169.2M | $278.1M | $46.3M |
| Jun 2022 | $186.5M | $297.2M | $55.3M |
| Sep 2022 | $195.1M | $364.3M | $35.8M |
| Dec 2022 | $210.9M | $352.9M | $28.0M |
| Mar 2023 | $192.4M | $333.5M | $49.4M |
| Jun 2023 | $365.0M | $443.6M | $297.2M |
| Sep 2023 | $381.6M | $650.6M | $303.1M |
| Dec 2023 | $398.0M | $646.6M | $286.3M |
| Mar 2024 | $417.4M | $652.0M | $302.8M |
| Jun 2024 | $431.8M | $660.8M | $233.2M |
| Sep 2024 | $435.9M | $667.9M | $223.0M |
| Dec 2024 | $445.1M | $670.8M | $222.5M |
| Mar 2025 | $457.0M | $690.2M | $211.8M |
| Jun 2025 | $470.7M | $725.8M | $228.1M |
| Sep 2025 | $493.1M | $785.1M | $282.0M |
| Dec 2025 | $528.1M | $842.8M | $296.7M |
| Mar 2026 | $648.4M | $890.9M | $324.9M |
| Jun 2026 | $1.06B | $1.04B | $330.7M |